Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 5Completed 3Enrolling by invitation 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Plasma cell 2Classical hematology 1

Conditions

Multiple Sclerosis 1Leukemia, Myeloid, Acute 1Leukemia 1Hematologic Neoplasms 1Hematologic Diseases 1

Interventions

Cytarabine 465Cyclophosphamide 459fludarabine phosphate 277Rituximab 249Methotrexate 245Etoposide 203fludarabine 200Filgrastim 199Peripheral Blood Stem Cell Transplantation 180Busulfan 169Vincristine 163Dexamethasone 153Daunorubicin 151Azacitidine 145Mycophenolic Acid 142Whole-Body Irradiation 133Tacrolimus 127Imatinib Mesylate 127Cyclosporine 123Granulocyte Colony-Stimulating Factor 118Radiotherapy 113Melphalan 110Idarubicin 103Doxorubicin 101Mitoxantrone 97Decitabine 97Antilymphocyte Serum 97Lenalidomide 96Mercaptopurine 93Prednisone 91

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Platelet Transfusion × Other hematologic neoplasm × Clear all
NCT04454723 2024-03-05

PalliaQOL

University of Oklahoma

Phase NA Completed
20 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT02601131 2016-11-29

Post-transfusion Platelet Count

Region Skane

Completed
80 enrolled
Other hematologic neoplasm

Leukemia, Multiple Sclerosis

NCT00000589 2016-11-07

Trial to Reduce Alloimmunization to Platelets (TRAP)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
Other hematologic neoplasm

Hematologic Diseases, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡